TREATMENT OF SUPERIOR VENA-CAVA THROMBOSIS WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR

被引：23

作者：

GREENBERG, S

KOSINSKI, R

DANIELS, J

机构：

[1] MONMOUTH MED CTR,DIV CARDIOL,LONG BRANCH,NJ 07740

[2] MONMOUTH MED CTR,DIV HEMATOL MED ONCOL,LONG BRANCH,NJ 07740

来源：

CHEST | 1991年 / 99卷 / 05期

关键词：

D O I：

10.1378/chest.99.5.1298

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

Thrombotic occlusion of the superior vena cava is an uncommon but serious complication of chronic indwelling venous catheters. Several reports have shown thrombolytic therapy with intravenous streptokinase or urokinase to be effective in the treatment of this condition. We report a case of superior vena cava thrombosis in a 53-year-old woman receiving chemotherapy for breast carcinoma through a subcutaneously implanted venous access catheter who was successfully treated with peripheral infusion of recombinant tissue type plasminogen activator (rtPA).

引用

页码：1298 / 1301

页数：4

共 19 条

[1] THROMBOLYSIS WITH HUMAN EXTRINSIC (TISSUE-TYPE) PLASMINOGEN-ACTIVATOR IN RABBITS WITH EXPERIMENTAL JUGULAR VEIN-THROMBOSIS - EFFECT OF MOLECULAR-FORM AND DOSE OF ACTIVATOR, AGE OF THE THROMBUS, AND ROUTE OF ADMINISTRATION [J].